Miscarried ‘cervical cancer vaccination,’ starting re-tender this week

Published: 2016-06-02 10:41:10

Updated: 2016-06-02 10:41:10

While the Public Procurement Service’s tender for Gardasil and Cervarix, the subject of the National Immunization Program for cervical cancer vaccination, was finally miscarried, the Korea Centers for Diseases Control and Prevention(KCDC) announced a plan to get on a re-tender within this week.

According to the KCDC on the 31^st, Gardasil(MSD) and Cervarix(GSK) were all miscarried at the recent...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.